Isabelle Huys
- Economics and Econometrics top 0.5%
- Health Systems, Economic Evaluations, Quality of Life 92
- Pharmaceutical Economics and Policy 78
- Microbiology top 1%
- Health Informatics top 2%
- Immunology top 5%
- Biosimilars and Bioanalytical Methods 52
- Ecology top 2%
-
- Pharmaceutical studies and practices 31
-
- Ethics in Clinical Research 27
-
- Biomedical Ethics and Regulation 27
-
- Patient-Provider Communication in Healthcare 16
-
- Intellectual Property and Patents 14
- Co-authors
- Steven SimoensArnold G. VultoMinne CasteelsGilbert VerbekenDaniël De VosEline van OverbeekeJean‐Paul PirnayKim Pauwels
- Journals
- Journal of Biological Chemistry (3 papers)SHILAP Revista de lepidopterología (5 papers)Nature Biotechnology (3 papers)
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
Isabelle Huys
208 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 175
- Economics and Econometrics 1.6k
- Microbiology 335
- Health Informatics 61
- Immunology 879
- Ecology 743
Countries citing papers authored by Isabelle Huys
This map shows the geographic impact of Isabelle Huys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Huys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Huys more than expected).
Fields of papers citing papers by Isabelle Huys
This network shows the impact of papers produced by Isabelle Huys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Huys. The network helps show where Isabelle Huys may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Isabelle Huys, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 17 | |
| 7 | 2020 | 17 | |
| 8 | 2020 | 29 | |
| 9 | 2020 | 52 | |
| 10 | 2020 | 16 | |
| 11 | 2020 | 7 | |
| 12 | 2020 | 22 | |
| 13 | 2020 | 9 | |
| 14 | 2020 | 32 | |
| 15 | 2019 | 25 | |
| 16 | 2019 | 85 | |
| 17 | 2015 | 4 | |
| 18 | 2014 | 32 | |
| 19 | 2013 | 21 | |
| 20 | Synthesis and Characterization of Spinoxin, a Novel Peptide Toxin from the Malaysian Black Scorpion | 2004 | 4 |
About Isabelle Huys
Isabelle Huys is a scholar working on Economics and Econometrics, Immunology and Management of Technology and Innovation, having authored 223 papers that have together received 4.5k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (92 papers), Pharmaceutical Economics and Policy (78 papers), Biosimilars and Bioanalytical Methods (52 papers), Pharmaceutical studies and practices (31 papers), Ethics in Clinical Research (27 papers), Biomedical Ethics and Regulation (27 papers), Patient-Provider Communication in Healthcare (16 papers) and Intellectual Property and Patents (14 papers). The work is most often cited by research in Economics and Econometrics (1.6k citations), Microbiology (335 citations) and Health Informatics (61 citations). Isabelle Huys has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Steven Simoens, Arnold G. Vulto, Minne Casteels, Gilbert Verbeken, Daniël De Vos, Eline van Overbeeke, Jean‐Paul Pirnay, Kim Pauwels, Paul Declerck and Liese Barbier. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.